Thema
Adalimumab
158
FYS6T7F842
158
Journal Article
110
Antibodies, Monoclonal, Humanized
78
Antibodies, Monoclonal
63
Etanercept
62
OP401G7OJC
62
Dermatologic Agents
56
B72HH48FLU
51
Infliximab
51
Research Support, Non-U.S. Gov't
46
FU77B4U5Z0
41
Letter
41
Ustekinumab
41
Tumor Necrosis Factor-alpha
39
Anti-Inflammatory Agents
37
Immunoglobulin G
31
Receptors, Tumor Necrosis Factor
30
Biological Products
29
Multicenter Study
26
Case Reports
22
Comment
22
Randomized Controlled Trial
17
Biological Factors
16
Methotrexate
14
YL5FZ2Y5U1
14
Comparative Study
13
Observational Study
12
Antirheumatic Agents
11
Clinical Trial, Phase III
10
Immunologic Factors
9
Review
8
Biosimilar Pharmaceuticals
7
Klinische Studie
7
DLG4EML025
6
Editorial
6
Immunosuppressive Agents
6
secukinumab
6
089658A12D
5
Meta-Analysis
5
RNA, Messenger
5
Systematic Review
5
guselkumab
5
Adjuvants, Immunologic
4
Anti-Inflammatory Agents, Non-Steroidal
4
Biomarkers
4
Clinical Trial, Phase II
4
Tumor Necrosis Factor Inhibitors
4
XX2MN88N5D
4
efalizumab
4
mehr ...